Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review

Peripheral neuropathy is the most common dose-limiting toxicity associated with oxaliplatin. We report on a 61-year-old female patient with advanced primary ampullary adenocarcinoma who received 35 cycles of FOLFIRINOX (5-fluorouracil, irinotecan, and oxaliplatin) chemotherapy. The patient has toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhari, Nedal, Winquist, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567005/
https://www.ncbi.nlm.nih.gov/pubmed/28868015
http://dx.doi.org/10.1159/000477841
_version_ 1783258639339880448
author Bukhari, Nedal
Winquist, Eric
author_facet Bukhari, Nedal
Winquist, Eric
author_sort Bukhari, Nedal
collection PubMed
description Peripheral neuropathy is the most common dose-limiting toxicity associated with oxaliplatin. We report on a 61-year-old female patient with advanced primary ampullary adenocarcinoma who received 35 cycles of FOLFIRINOX (5-fluorouracil, irinotecan, and oxaliplatin) chemotherapy. The patient has tolerated this treatment without developing significant peripheral neuropathy.
format Online
Article
Text
id pubmed-5567005
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-55670052017-09-01 Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review Bukhari, Nedal Winquist, Eric Case Rep Oncol Case Report Peripheral neuropathy is the most common dose-limiting toxicity associated with oxaliplatin. We report on a 61-year-old female patient with advanced primary ampullary adenocarcinoma who received 35 cycles of FOLFIRINOX (5-fluorouracil, irinotecan, and oxaliplatin) chemotherapy. The patient has tolerated this treatment without developing significant peripheral neuropathy. S. Karger AG 2017-06-29 /pmc/articles/PMC5567005/ /pubmed/28868015 http://dx.doi.org/10.1159/000477841 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Bukhari, Nedal
Winquist, Eric
Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review
title Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review
title_full Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review
title_fullStr Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review
title_full_unstemmed Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review
title_short Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review
title_sort chronic oxaliplatin-based chemotherapy in a primary ampullary adenocarcinoma patient without significant peripheral neuropathy: case report and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567005/
https://www.ncbi.nlm.nih.gov/pubmed/28868015
http://dx.doi.org/10.1159/000477841
work_keys_str_mv AT bukharinedal chronicoxaliplatinbasedchemotherapyinaprimaryampullaryadenocarcinomapatientwithoutsignificantperipheralneuropathycasereportandliteraturereview
AT winquisteric chronicoxaliplatinbasedchemotherapyinaprimaryampullaryadenocarcinomapatientwithoutsignificantperipheralneuropathycasereportandliteraturereview

Ejemplares similares